Sage Therapeutics stock plunges more than 50% after FDA decision on postpartum depression drug
Advertise here In this photograph illustration, the Sage Therapeutics emblem of a biopharmaceutical firm seen on a smartphone and on a laptop display. Pavlo Gonchar | SOPA Images | Lightrocket…